Article Text

Download PDFPDF
S139 A Paradoxical Rise In Rectus Femoris Myostatin (gdf-8) And Gdf-15 In Response To Neuromuscular Electrical Stimulation In Critical Care
  1. SAA Bloch1,
  2. T Syburrah2,
  3. U Rosendahl2,
  4. PR Kemp1,
  5. MJD Griffiths3,
  6. MI Polkey3
  1. 1Imperial College, London, UK
  2. 2Royal Brompton and Harefield NHS, London, UK
  3. 3NIHR BRU at Royal Brompton, London, UK


Introduction Neuromuscular electrical stimulation (NMES) is widely used in rehabilitation and muscle disease. Recently there is increasing interest in its use as a prevention and treatment for intensive care unit acquired weakness (ICUAW). ICUAW is a common and often devastating disease resulting as a consequence of critical illness. The molecular mechanisms are not understood, however early mobilisation and rehabilitation are to date the most effective treatments. NMES has been shown to help prevent muscle wasting in some clinical studies in the ICU setting, however the evidence is inconclusive. We hypothesised that the NMES of a single leg in critical care patients would be associated with reduced muscle wasting and down regulation of molecular pathways involved in muscle breakdown. Specifically myostatin (GDF-8), a potent negative regulator of muscle mass, and GDF-15, a potential novel driver of muscle atropy.

Methods We conducted a single-blinded, single leg, contralateral controlled trial of NMES in patients admitted to a specialist cardiothoracic ICU. Patients were recruited prior to elective high-risk cardiac surgery or during ICU admission. Baseline bilateral rectus femoris cross sectional area (RFcsa) was measured by ultrasound and rectus femoris biopsies were taken. 2 × 1 hour sessions of NMES were then conducted for 1 week and ultrasound and biopsies were repeated. Biopsy specimens were examined for mRNA expression of genes of interest and results analysed in paired analysis relative to baseline. (NCT01321320).

Results 12 patients completed the study protocol. Myostatin and GDF-15 mRNA expression were both significantly elevated in NMES legs compared to baseline (p = 0.03 and p = 0.04 respectively), but remained unchanged in control legs. There was no significant change in RFcsa.

Discussion It is believed that NMES will have beneficial effects in the ICU setting in terms of preservation of muscle function. However it is recognised to also have potential to cause muscle damage. In the setting of sedated patients who cannot report pain or those in whom the nutritional and metabolic status of the muscle may be expected to be poor, researchers should be aware that NMES may promote muscle breakdown.

Abstract S139 Figure 1

Rectus Femoris mRNA expression of Myostatin or GDF-15 in ICU patients (n = 12) relative to baseline (pre) and following 1 week of neuromusclular electrical stimulation (NMES) or control. *p < 0.05 Wilcoxon paired analysis of post study comparison relative to baseline

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.